Nutex Health (NUTX) stock trading at 'absurd' EV/AEBITDA Multiple, remains a a ' Benchmark Best Idea'
Tweet Send to a Friend
Benchmark analyst Bill Sutherland reiterated a Buy rating and $300.00 price target on Nutex Health (NASDAQ: NUTX).The analyst commented, "NUTX ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
